g.tec medical engineering develops advanced neurotechnology solutions, including brain-computer interfaces (BCIs) and high-precision biosignal acquisition systems, enabling researchers and clinicians to measure and interpret brain activity with exceptional accuracy.
Through strong collaboration with scientific and medical institutions, the company translates neuroscience into practical applications that support neurorehabilitation, clinical research, and innovative human–machine interaction.
g.tec develops integrated platforms for brain–computer interfaces (BCIs), combining hardware, software, and application frameworks into a unified ecosystem used in research and clinical environments worldwide. The company's technology enables real-time biosignal acquisition, processing, and machine learning integration, supporting reproducible development across laboratories and hospitals.
With a global network spanning over 140 countries, g.tec fosters collaboration through initiatives like the Spring School and BR41N.IO Hackathons, described as the 'Woodstock of neurotechnology.' The company's solutions are trusted by leading institutions including NASA, MIT, Google, and Harvard, and have contributed to over 330 peer-reviewed publications in top journals such as Nature and Frontiers.
